RCM-1 [Human rectal adenocarcinoma]
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1648
|
Homo sapiens (Human)
|
Rectal adenocarcinoma
|
Population: Japanese., Part of: NCI RAS program mutant KRAS cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: AstraZeneca Colorectal cell line (AZCL) panel.
|
PMID:2570482 PMID:3198327 PMID:8348978 PMID:9247707 PMID:9290701 PMID:16418264 PMID:18258742 PMID:20164919 PMID:20215515 PMID:20606684 PMID:22460905 PMID:23272949 PMID:25485619 PMID:25877200 PMID:25926053 PMID:26589293 PMID:27397505 PMID:28854368 PMID:29101300 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
RCM1 |
|
|
CLO:CLO_0009972, EFO:EFO_0006476, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:996, BioSample:SAMN03472886, BioSample:SAMN10988165, cancercelllines:CVCL_1648, Cell_Model_Passport:SIDM00359, ChEMBL-Cells:CHEMBL3308125, ChEMBL-Targets:CHEMBL1075562, ColonAtlas:RCM1, Cosmic:873704, Cosmic:909263, Cosmic:1122329, Cosmic:1184088, Cosmic:1187314, Cosmic:1995616, Cosmic-CLP:909263, DepMap:ACH-000565, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:909263, GEO:GSM827229, GEO:GSM887526, GEO:GSM888608, GEO:GSM1374846, GEO:GSM1448098, GEO:GSM1670367, IARC_TP53:21282, JCRB:JCRB0256, LiGeA:CCLE_779, LINCS_LDP:LCL-1290, PharmacoDB:RCM1_1295_2019, PRIDE:PXD005235, PRIDE:PXD005354, PRIDE:PXD005355, PRIDE:PXD030304, Progenetix:CVCL_1648, PubChem_Cell_line:CVCL_1648, Wikidata:Q54949516 |
|
|
CVCL_1648 |
2026-07-25 04:59:50 |
5 |
RD-ES
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_2169
|
Homo sapiens (Human)
|
Ewing sarcoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8040301 PMID:8221663 PMID:8378080 PMID:9738976 PMID:11423975 PMID:18082704 PMID:18160777 PMID:19787792 PMID:20215515 PMID:21822310 PMID:22142829 PMID:22460905 PMID:25010205 PMID:25223734 PMID:25877200 PMID:26351324 PMID:26428435 PMID:28196595 PMID:29464090 PMID:30879952 PMID:30894373 PMID:31068700 PMID:36476851
|
Cancer cell line
|
Male |
RDES, RDES-1 |
|
|
BTO:BTO_0004202, CLO:CLO_0008774, EFO:EFO_0002316, CLDB:cl4128, CLDB:cl4129, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:HTB-166, BCRJ:0267, BioGRID_ORCS_Cell_line:194, BioSample:SAMN03470929, BioSample:SAMN10987904, cancercelllines:CVCL_2169, Cell_Model_Passport:SIDM01316, CLS:300410, Cosmic:759890, Cosmic:1078386, Cosmic:1082506, Cosmic:1085906, Cosmic:1381107, Cosmic:1718429, Cosmic:2228230, Cosmic:2250477, Cosmic:2294586, DepMap:ACH-000041, DSMZ:ACC-260, DSMZCellDive:ACC-260, GDSC:1330996, GEO:GSM393042, GEO:GSM510006, GEO:GSM887527, GEO:GSM888609, GEO:GSM1676310, GEO:GSM1701644, GEO:GSM5359730, GEO:GSM5359731, GEO:GSM5359732, GEO:GSM5359733, GEO:GSM5359734, GEO:GSM5359735, GEO:GSM5362971, GEO:GSM5362972, GEO:GSM5362973, GEO:GSM5362974, GEO:GSM5362975, GEO:GSM5362976, GEO:GSM5363991, GEO:GSM5363992, GEO:GSM5363993, GEO:GSM5363994, GEO:GSM5363995, IARC_TP53:1272, IARC_TP53:8400, IGRhCellID:RDES, LiGeA:CCLE_906, LINCS_LDP:LCL-1455, PharmacoDB:RDES_1297_2019, Progenetix:CVCL_2169, Wikidata:Q54949536 |
|
|
CVCL_2169 |
2026-07-25 04:59:51 |
10 |
RD
Resource Report
Resource Website
10+ mentions
Discontinued Discontinued Discontinued
|
RRID:CVCL_1649
|
Homo sapiens (Human)
|
Embryonal rhabdomyosarcoma
|
Anecdotal: One of the 3 cell lines (HT-1080, RD and SK-N-SH) where the NRAS oncogene was first identified (PubMed=6304521)., Population: Caucasian., Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:77569 PMID:327080 PMID:833871 PMID:1917385 PMID:2216456 PMID:2302710 PMID:3158613 PMID:3518877 PMID:4241949 PMID:6220172 PMID:6304521 PMID:7309287 PMID:8275086 PMID:8383879 PMID:10899454 PMID:12068308 PMID:16518851 PMID:17471488 PMID:18082704 PMID:19235922 PMID:20164919 PMID:20215515 PMID:20922763 PMID:21948088 PMID:22142829 PMID:22460905 PMID:22541669 PMID:23578105 PMID:23828214 PMID:23882450 PMID:25894527 PMID:26351324 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:31448612 PMID:31978347 PMID:35839778 PMID:36768928
|
Cancer cell line
|
Female |
R D, RD-2, RD 2, 130T, 130-T, 130 T, TE-32, TE 32, TE32, TE 32.T, Te 32.T |
|
|
BTO:BTO_0005377, CLO:CLO_0008693, CLO:CLO_0008770, EFO:EFO_0002315, CLDB:cl4119, CLDB:cl4120, CLDB:cl4121, CLDB:cl4122, CLDB:cl4123, CLDB:cl4124, CLDB:cl4125, CLDB:cl4126, CLDB:cl4127, AddexBio:C0035001/4950, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CCL-136, ATCC:CRL-7713, ATCC:CRL-7731, ATCC:HTB-97, BCRC:60113, BCRJ:0260, BioGRID_ORCS_Cell_line:482, BioSample:SAMN01821591, BioSample:SAMN01821716, BioSample:SAMN03472710, BioSample:SAMN10988441, cancercelllines:CVCL_1649, CCRID:1101HUM-PUMC000293, CCRID:1102HUM-NIFDC00079, CCRID:3101HUMTCHu45, CCRID:4201HUM-CCTCC00295, CCTCC:GDC0295, Cell_Model_Passport:SIDM00847, ChEMBL-Cells:CHEMBL3307547, ChEMBL-Targets:CHEMBL614144, CLS:300401, Cosmic:724833, Cosmic:801358, Cosmic:801760, Cosmic:802045, Cosmic:909264, Cosmic:1037298, Cosmic:1048111, Cosmic:1097753, Cosmic:1309330, Cosmic:1509195, Cosmic:1620036, Cosmic:1718099, Cosmic:2296987, Cosmic:2301590, Cosmic:2355912, Cosmic-CLP:909264, DepMap:ACH-000169, ECACC:85111502, EGA:EGAS00001000978, GDSC:909264, GEO:GSM185149, GEO:GSM186446, GEO:GSM219726, GEO:GSM887528, GEO:GSM888610, GEO:GSM1012752, GEO:GSM1670368, GEO:GSM1676309, GEO:GSM1701643, IARC_TP53:767, IGRhCellID:RD, IZSLER:BS TCL 57, JCRB:JCRB9072, KCLB:10136, LiGeA:CCLE_882, LINCS_LDP:LCL-1411, Lonza:1536, PharmacoDB:RD_1296_2019, PRIDE:PXD000589, PRIDE:PXD007755, PRIDE:PXD030304, PRIDE:PXD039480, Progenetix:CVCL_1649, PubChem_Cell_line:CVCL_1649, TOKU-E:2986, Wikidata:Q54949532 |
|
|
CVCL_1649 |
2026-07-25 04:59:51 |
47 |
RERF-LC-Ad2
Resource Report
Resource Website
Discontinued
|
RRID:CVCL_1652
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Japanese., Part of: NCI RAS program mutant KRAS cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:16105816 PMID:20215515 PMID:22460905 PMID:30894373 PMID:31068700
|
Cancer cell line
|
Male |
RERF-LC-AD2, RERFLCAD2, RERFLCAd2, Radiation Effects Research Foundation-Lung Cancer-Adenocarcinoma 2 |
|
|
ArrayExpress:E-MTAB-2770, BioSample:SAMN03472536, BioSample:SAMN10987625, cancercelllines:CVCL_1652, Cell_Model_Passport:SIDM01332, Cosmic:946062, DepMap:ACH-000774, GEO:GSM827564, GEO:GSM887533, GEO:GSM888615, IARC_TP53:28364, IARC_TP53:30151, JCRB:JCRB1021, JCRB:NIHS0278, LiGeA:CCLE_354, PharmacoDB:RERFLCAd2_1302_2019, Progenetix:CVCL_1652, Wikidata:Q54949760 |
|
|
CVCL_1652 |
2026-07-25 04:59:54 |
0 |
RERF-LC-KJ
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1654
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7790314 PMID:15746151 PMID:15901131 PMID:16105816 PMID:20215515 PMID:21559605 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778 PMID:38639832
|
Cancer cell line
|
Male |
RERFLCKJ, KJ, Radiation Effects Research Foundation-Lung Cancer-KJ |
|
|
CLO:CLO_0050047, EFO:EFO_0002851, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03470804, BioSample:SAMN03472623, BioSample:SAMN10988172, cancercelllines:CVCL_1654, Cell_Model_Passport:SIDM00356, CGH-DB:208-1, Cosmic:946063, Cosmic:1154603, Cosmic:1571721, Cosmic-CLP:1298537, DepMap:ACH-000482, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1298537, GEO:GSM274674, GEO:GSM784282, GEO:GSM827375, GEO:GSM887535, GEO:GSM888617, GEO:GSM1670372, IARC_TP53:21635, JCRB:JCRB0137, JCRB:NIHS0210, LiGeA:CCLE_848, LINCS_LDP:LCL-1658, PharmacoDB:RERFLCKJ_1305_2019, PRIDE:PXD030304, Progenetix:CVCL_1654, RCB:RCB1313, Wikidata:Q54949763 |
|
|
CVCL_1654 |
2026-07-25 04:59:54 |
1 |
PLC/PRF/5
Resource Report
Resource Website
500+ mentions
Discontinued
|
RRID:CVCL_0485
|
Homo sapiens (Human)
|
Adult hepatocellular carcinoma
|
Caution: Often called PLC8024 in Chinese literature probably because of a concatenation between PLC/PRF/5 and ATCC-8024., Karyotypic information: Has lost chromosome Y., Virology: Susceptible to infection by adenovirus types 40 (Ad40) and 41 (Ad41) (PubMed=1317878)., Virology: Contains at least 7 copies of integrated hepatitis B virus (HBV) genomes. Secretes hepatitis virus B surface antigen (HBsAg) but no other HBV proteins (PubMed=6302689; PubMed=6317496)., Population: African; Shangaan., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:63998 PMID:184551 PMID:187208 PMID:1317878 PMID:1661347 PMID:2414854 PMID:2439335 PMID:2542205 PMID:2992761 PMID:2992762 PMID:3023526 PMID:3431441 PMID:6160110 PMID:6225510 PMID:6248960 PMID:6268737 PMID:6275024 PMID:6288577 PMID:6302689 PMID:6317496 PMID:6555060 PMID:6889516 PMID:7874267 PMID:8050184 PMID:8224613 PMID:8389256 PMID:8835345 PMID:9023415 PMID:9178645 PMID:9290701 PMID:9359923 PMID:10523694 PMID:11050057 PMID:12029633 PMID:15767549 PMID:20069059 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23505090 PMID:23887712 PMID:25485619 PMID:25574106 PMID:25877200 PMID:26589293 PMID:28196595 PMID:29892436 PMID:30894373 PMID:31063779 PMID:31068700 PMID:31378681
|
Cancer cell line
|
Male |
PLC-PRF-5, PLC PRF 5, PLC/PRF5, PLCPRF5, PLC-8024, PLC8024, PLC, Alexander cells, Alexander, Primary Liver Carcinoma/Poliomyelitis Research Foundation/5 |
|
|
BTO:BTO_0003492, CLO:CLO_0008458, CLO:CLO_0008459, EFO:EFO_0006291, MCCL:MCC:0000384, CLDB:cl3914, CLDB:cl3915, CLDB:cl3916, CLDB:cl5248, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CRL-8024, BCRC:60223, BCRJ:0274, BioGRID_ORCS_Cell_line:484, BioSample:SAMN03471130, BioSample:SAMN03473236, BioSample:SAMN10988112, cancercelllines:CVCL_0485, CCRID:1101HUM-PUMC000674, CCRID:1102HUM-NIFDC00071, CCRID:3101HUMTCHu119, CCRID:4201HUM-CCTCC00644, Cell_Model_Passport:SIDM01318, CGH-DB:9070-4, ChEMBL-Cells:CHEMBL3308140, ChEMBL-Targets:CHEMBL1075561, CLS:300315, Cosmic:721061, Cosmic:808505, Cosmic:871514, Cosmic:873402, Cosmic:925349, Cosmic:945155, Cosmic:948065, Cosmic:1019318, Cosmic:1351513, Cosmic:1518224, Cosmic:2023861, Cosmic:2162538, Cosmic:2321033, Cosmic:2674231, Cosmic:2773187, DepMap:ACH-001318, ECACC:85061113, EGA:EGAS00001000610, GDSC:925349, GEO:GSM207051, GEO:GSM565881, GEO:GSM827153, GEO:GSM886865, GEO:GSM887520, GEO:GSM887930, GEO:GSM888602, GEO:GSM936773, GEO:GSM2551580, GEO:GSM2551581, IARC_TP53:107, IARC_TP53:30016, IZSLER:BS TCL 122, JCRB:IFO50069, JCRB:JCRB0406, KCB:KCB 200785YJ, KCLB:28024, LiGeA:CCLE_292, LIMORE:PLC8024, LIMORE:PLCPRF5, LINCS_LDP:LCL-1942, NCBI_Iran:C145, PharmacoDB:PLCPRF5_1274_2019, Progenetix:CVCL_0485, PubChem_Cell_line:CVCL_0485, RCB:RCB1887, TKG:TKG 0376, TOKU-E:2898, Ubigene:YC-C125, Wikidata:Q54947574 |
|
|
CVCL_0485 |
2026-07-25 04:59:14 |
574 |
PNT2
Resource Report
Resource Website
10+ mentions
|
ECACC Cat# 95012613, RRID:CVCL_2164
|
Homo sapiens (Human)
|
|
|
PMID:11135431 PMID:11416159 PMID:17644708 PMID:20215515 PMID:21556542
|
Transformed cell line
|
Male |
PNT 2, PNT-2 |
ECACC |
95012613 |
BTO:BTO_0002399, CLO:CLO_0008476, EFO:EFO_0022595, CLDB:cl3927, ChEMBL-Cells:CHEMBL4632325, ChEMBL-Targets:CHEMBL4632332, ECACC:95012613, GEO:GSM827351, PubChem_Cell_line:CVCL_2164, Wikidata:Q54947682 |
|
|
CVCL_2164 |
2026-07-25 04:59:16 |
11 |
PNT2
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_2164
|
Homo sapiens (Human)
|
|
|
PMID:11135431 PMID:11416159 PMID:17644708 PMID:20215515 PMID:21556542
|
Transformed cell line
|
Male |
PNT 2, PNT-2 |
|
|
BTO:BTO_0002399, CLO:CLO_0008476, EFO:EFO_0022595, CLDB:cl3927, ChEMBL-Cells:CHEMBL4632325, ChEMBL-Targets:CHEMBL4632332, ECACC:95012613, GEO:GSM827351, PubChem_Cell_line:CVCL_2164, Wikidata:Q54947682 |
|
|
CVCL_2164 |
2026-07-25 04:59:17 |
11 |
PWR-1E
Resource Report
Resource Website
1+ mentions
|
ATCC Cat# CRL-11611, RRID:CVCL_3775
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:8761420 PMID:8977636 PMID:20215515 PMID:27397505 PMID:30894373 PMID:35839778
|
Transformed cell line
|
Male |
PWR1E |
ATCC |
CRL-11611 |
BTO:BTO_0005178, CLO:CLO_0008671, ArrayExpress:E-MTAB-3610, ATCC:CRL-11611, BioSample:SAMN03471342, cancercelllines:CVCL_3775, Cell_Model_Passport:SIDM01114, ChEMBL-Cells:CHEMBL4295467, ChEMBL-Targets:CHEMBL4296487, Cosmic-CLP:1330993, DepMap:ACH-001383, EGA:EGAS00001000978, GDSC:1330993, GEO:GSM827268, GEO:GSM1670354, PharmacoDB:PWR1E_1279_2019, PRIDE:PXD030304, Progenetix:CVCL_3775, PubChem_Cell_line:CVCL_3775, Wikidata:Q54948720 |
|
|
CVCL_3775 |
2026-07-25 04:59:37 |
1 |
RPMI-8226
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0014
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine., Characteristics: Produces IgG lambda (PubMed=6042436; ATCC=CCL-155)., Population: African American., Part of: NCI-7 clinical proteomics reference material cell line panel., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1373872 PMID:1720489 PMID:2041050 PMID:2140233 PMID:2537114 PMID:2563664 PMID:2875788 PMID:2985879 PMID:3159941 PMID:3874327 PMID:3893568 PMID:4177524 PMID:4366935 PMID:5243066 PMID:5260617 PMID:6042436 PMID:6350451 PMID:8943038 PMID:9290701 PMID:9331090 PMID:9510473 PMID:10087940 PMID:10557056 PMID:10583232 PMID:10700174 PMID:10936422 PMID:11001907 PMID:11154231 PMID:11157491 PMID:11515052 PMID:12068308 PMID:14555701 PMID:15215163 PMID:15748285 PMID:16956823 PMID:16957166 PMID:17088437 PMID:17171682 PMID:17692805 PMID:18277095 PMID:18605421 PMID:18647998 PMID:18700954 PMID:19306352 PMID:19372543 PMID:20164919 PMID:20215515 PMID:21173094 PMID:22068913 PMID:22347499 PMID:22384151 PMID:22460905 PMID:22628656 PMID:23074853 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24670534 PMID:25485619 PMID:25688540 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:29718670 PMID:30285677 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31160637 PMID:31465861 PMID:31733513 PMID:31978347 PMID:32123307 PMID:35839778 PMID:38861359
|
Cancer cell line
|
Male |
RPMI 8226, RPMI.8226, RPMI8226, RPMI no. 8226, RPMI no 8226, RPMI #8226, 8226, RPMI 8226/S, RPMI-8226S, RPMI8226/S, 8226/S, Roswell Park Memorial Institute 8226, GM02132, GM2132, GM 2132, GM02132C, Simpson |
|
|
BTO:BTO_0000726, CLO:CLO_0008873, CLO:CLO_0031845, EFO:EFO_0002322, MCCL:MCC:0000406, CLDB:cl4182, CLDB:cl4183, CLDB:cl4184, CLDB:cl5252, AddexBio:C0003002/62, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ArrayExpress:E-TABM-937, ATCC:CCL-155, ATCC:CRM-CCL-155, BCRC:60384, BioGRID_ORCS_Cell_line:1003, BioSample:SAMN03471458, BioSample:SAMN03472934, BioSample:SAMN03473581, BioSample:SAMN10988318, cancercelllines:CVCL_0014, CCRID:1101HUM-PUMC000083, CCRID:3101HUMTCHu234, Cell_Model_Passport:SIDM00087, CGH-DB:9162-4, ChEMBL-Cells:CHEMBL3307732, ChEMBL-Targets:CHEMBL614882, CLS:300431, Coriell:GM02132, Cosmic:720773, Cosmic:724856, Cosmic:742952, Cosmic:759915, Cosmic:760397, Cosmic:875867, Cosmic:886084, Cosmic:888018, Cosmic:897452, Cosmic:905964, Cosmic:919145, Cosmic:974250, Cosmic:991554, Cosmic:999791, Cosmic:1044255, Cosmic:1092628, Cosmic:1139509, Cosmic:1139639, Cosmic:1175858, Cosmic:1305340, Cosmic:1312326, Cosmic:1762461, Cosmic:1998470, Cosmic:2081405, Cosmic:2159574, Cosmic:2367260, Cosmic:2391801, Cosmic-CLP:905964, DepMap:ACH-000817, DSMZ:ACC-402, DSMZCellDive:ACC-402, ECACC:87012702, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, ENCODE:ENCBS457ZNO, ENCODE:ENCBS604KZU, GDSC:905964, GEO:GSM2135, GEO:GSM50198, GEO:GSM50261, GEO:GSM143340, GEO:GSM290304, GEO:GSM562819, GEO:GSM621590, GEO:GSM743461, GEO:GSM750813, GEO:GSM799349, GEO:GSM799412, GEO:GSM887548, GEO:GSM888631, GEO:GSM1153419, GEO:GSM1181289, GEO:GSM1181334, GEO:GSM1199922, GEO:GSM1199923, GEO:GSM1199924, GEO:GSM1199925, GEO:GSM1199926, GEO:GSM1199927, GEO:GSM1374855, GEO:GSM1666389, GEO:GSM1670389, GEO:GSM2124680, GEO:GSM7701441, GEO:GSM7701457, IARC_TP53:360, IARC_TP53:27232, IGRhCellID:RPMI8226, IZSLER:BS TCL 92, JCRB:IFO50013, JCRB:JCRB0034, KCLB:10155, LiGeA:CCLE_817, LINCS_LDP:LCL-2049, Lonza:61, NCBI_Iran:C210, NCI-DTP:RPMI-8226, PharmacoDB:RPMI8226_1327_2019, PRIDE:PXD001276, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD013859, PRIDE:PXD030239, PRIDE:PXD030304, Progenetix:CVCL_0014, PubChem_Cell_line:CVCL_0014, RCB:RCB3010, SKY/M-FISH/CGH:2743, TKG:TKG 0243, Wikidata:Q54951245 |
|
|
CVCL_0014 |
2026-07-25 05:00:19 |
762 |
RPMI-6666
Resource Report
Resource Website
1+ mentions
Misclassified
|
KCLB Cat# 10113, RRID:CVCL_1665
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=20143388; PubMed=29533902)..
|
PMID:11515052 PMID:12133989 PMID:12592342 PMID:20143388 PMID:20164919 PMID:20215515 PMID:22460905 PMID:27397505 PMID:29533902 PMID:30894373 PMID:31068700 PMID:35839778
|
Transformed cell line
|
Male |
RPMI 6666, RPMI6666, Roswell Park Memorial Institute 6666 |
KCLB |
10113 |
CLO:CLO_0008870, EFO:EFO_0002321, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:CCL-113, BioSample:SAMN03151630, BioSample:SAMN03472694, BioSample:SAMN10988187, Cell_Model_Passport:SIDM00813, ChEMBL-Cells:CHEMBL3308884, ChEMBL-Targets:CHEMBL2366187, Cosmic:684228, Cosmic:909701, Cosmic-CLP:909701, DepMap:ACH-001182, ECACC:87081807, EGA:EGAS00001000978, GDSC:909701, GEO:GSM887546, GEO:GSM888629, GEO:GSM1670387, IARC_TP53:21291, IGRhCellID:RPMI6666, KCLB:10113, LINCS_LDP:LCL-2013, PharmacoDB:RPMI6666_1325_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1665, Wikidata:Q54951196 |
|
|
CVCL_1665 |
2026-07-25 05:00:18 |
2 |
RPMI-6666
Resource Report
Resource Website
1+ mentions
Misclassified
|
ATCC Cat# CCL-113, RRID:CVCL_1665
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but is a B-lymphoblastoid cell line (PubMed=12592342; PubMed=20143388; PubMed=29533902)..
|
PMID:11515052 PMID:12133989 PMID:12592342 PMID:20143388 PMID:20164919 PMID:20215515 PMID:22460905 PMID:27397505 PMID:29533902 PMID:30894373 PMID:31068700 PMID:35839778
|
Transformed cell line
|
Male |
RPMI 6666, RPMI6666, Roswell Park Memorial Institute 6666 |
ATCC |
CCL-113 |
CLO:CLO_0008870, EFO:EFO_0002321, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:CCL-113, BioSample:SAMN03151630, BioSample:SAMN03472694, BioSample:SAMN10988187, Cell_Model_Passport:SIDM00813, ChEMBL-Cells:CHEMBL3308884, ChEMBL-Targets:CHEMBL2366187, Cosmic:684228, Cosmic:909701, Cosmic-CLP:909701, DepMap:ACH-001182, ECACC:87081807, EGA:EGAS00001000978, GDSC:909701, GEO:GSM887546, GEO:GSM888629, GEO:GSM1670387, IARC_TP53:21291, IGRhCellID:RPMI6666, KCLB:10113, LINCS_LDP:LCL-2013, PharmacoDB:RPMI6666_1325_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1665, Wikidata:Q54951196 |
|
|
CVCL_1665 |
2026-07-25 05:00:18 |
2 |
RT-4
Resource Report
Resource Website
10+ mentions
Discontinued
|
RRID:CVCL_0036
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: TCGA-110-CL cell line panel., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ERK genetic alteration cell panel (ATCC TCP-1033)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:77569 PMID:327080 PMID:571047 PMID:833871 PMID:864752 PMID:870558 PMID:1114348 PMID:3518877 PMID:3708594 PMID:5503601 PMID:6220172 PMID:6244232 PMID:6582512 PMID:6823318 PMID:7017212 PMID:7459858 PMID:7787250 PMID:8873383 PMID:9850064 PMID:11207054 PMID:11921286 PMID:15846775 PMID:16885334 PMID:16957166 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23401075 PMID:24018021 PMID:24035680 PMID:24367658 PMID:25485619 PMID:25877200 PMID:25960936 PMID:25997541 PMID:26055179 PMID:26589293 PMID:27270441 PMID:27397505 PMID:28855393 PMID:29732388 PMID:30894373 PMID:31068700 PMID:31395879 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
RT4, RT4P |
|
|
BTO:BTO_0002870, CLO:CLO_0008892, EFO:EFO_0006480, CLDB:cl4197, CLDB:cl4198, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-7937, ATCC:HTB-2, BCRC:60111, BCRJ:0214, BioGRID_ORCS_Cell_line:382, BioSample:SAMN03473092, BioSample:SAMN10988330, cancercelllines:CVCL_0036, CCRID:3101HUMTCHu226, CCRID:5301HUM-KCB16045YJ, Cell_Model_Passport:SIDM01085, ChEMBL-Cells:CHEMBL3307430, ChEMBL-Targets:CHEMBL614884, CLS:300326, Cosmic:687455, Cosmic:715805, Cosmic:755396, Cosmic:760479, Cosmic:845560, Cosmic:846283, Cosmic:867839, Cosmic:925819, Cosmic:928816, Cosmic:943749, Cosmic:1016881, Cosmic:1046681, Cosmic:1068091, Cosmic:1285125, Cosmic:1285983, Cosmic:1819325, Cosmic:1927301, Cosmic:2037955, Cosmic:2050460, Cosmic:2057455, Cosmic:2444250, Cosmic:2686112, Cosmic:2700996, Cosmic-CLP:687455, DepMap:ACH-000242, DSMZ:ACC-412, DSMZCellDive:ACC-412, ECACC:91091914, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:687455, GEO:GSM136232, GEO:GSM763024, GEO:GSM827439, GEO:GSM887553, GEO:GSM888636, GEO:GSM1374859, GEO:GSM1574570, GEO:GSM1670394, GEO:GSM7701369, GEO:GSM7701370, IARC_TP53:21088, KCB:KCB 2016045YJ, KCLB:30002, LiGeA:CCLE_210, LINCS_LDP:LCL-1717, PharmacoDB:RT4_1334_2019, PRIDE:PXD030304, Progenetix:CVCL_0036, PubChem_Cell_line:CVCL_0036, SKY/M-FISH/CGH:1462, Wikidata:Q54951351 |
|
|
CVCL_0036 |
2026-07-25 05:00:22 |
30 |
RWPE-1
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_3791
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: ENCODE project common cell types; tier 3., Group: Patented cell line.
|
PMID:8977636 PMID:9214605 PMID:9214606 PMID:20215515 PMID:22275356 PMID:25877200 PMID:27397505 PMID:30305041 PMID:30787054
|
Transformed cell line
|
Male |
RWPE1 |
|
|
BTO:BTO_0003709, CLO:CLO_0008905, EFO:EFO_0002323, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-3610, ATCC:CRL-3607, ATCC:CRL-11609, BCRJ:0389, BioSample:SAMN03470832, BioSample:SAMN05292437, BioSample:SAMN07709991, BioSample:SAMN07709992, BioSample:SAMN07709993, BioSample:SAMN07709994, BioSample:SAMN07709995, BioSample:SAMN07709996, BioSample:SAMN07709997, cancercelllines:CVCL_3791, CCRID:3101HUMGNHu37, CCRID:3101HUMSCSP5025, CCRID:4201HUM-CCTCC00178, CCTCC:GDC0178, Cell_Model_Passport:SIDM00020, ChEMBL-Cells:CHEMBL4295468, ChEMBL-Targets:CHEMBL4296492, CLS:305217, EGA:EGAS00001000978, ENCODE:ENCBS124FCL, ENCODE:ENCBS192LWI, ENCODE:ENCBS263AAA, ENCODE:ENCBS875FPF, GEO:GSM827387, GEO:GSM1008595, GEO:GSM1374860, GEO:GSM1670396, IGRhCellID:RWPE1, Lonza:870, PharmacoDB:RWPE1_1336_2019, Progenetix:CVCL_3791, PubChem_Cell_line:CVCL_3791, Wikidata:Q54951497 |
|
|
CVCL_3791 |
2026-07-25 05:00:25 |
723 |
RWPE-1
Resource Report
Resource Website
500+ mentions
|
CCTCC Cat# GDC0178, RRID:CVCL_3791
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: ENCODE project common cell types; tier 3., Group: Patented cell line.
|
PMID:8977636 PMID:9214605 PMID:9214606 PMID:20215515 PMID:22275356 PMID:25877200 PMID:27397505 PMID:30305041 PMID:30787054
|
Transformed cell line
|
Male |
RWPE1 |
CCTCC |
GDC0178 |
BTO:BTO_0003709, CLO:CLO_0008905, EFO:EFO_0002323, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-3610, ATCC:CRL-3607, ATCC:CRL-11609, BCRJ:0389, BioSample:SAMN03470832, BioSample:SAMN05292437, BioSample:SAMN07709991, BioSample:SAMN07709992, BioSample:SAMN07709993, BioSample:SAMN07709994, BioSample:SAMN07709995, BioSample:SAMN07709996, BioSample:SAMN07709997, cancercelllines:CVCL_3791, CCRID:3101HUMGNHu37, CCRID:3101HUMSCSP5025, CCRID:4201HUM-CCTCC00178, CCTCC:GDC0178, Cell_Model_Passport:SIDM00020, ChEMBL-Cells:CHEMBL4295468, ChEMBL-Targets:CHEMBL4296492, CLS:305217, EGA:EGAS00001000978, ENCODE:ENCBS124FCL, ENCODE:ENCBS192LWI, ENCODE:ENCBS263AAA, ENCODE:ENCBS875FPF, GEO:GSM827387, GEO:GSM1008595, GEO:GSM1374860, GEO:GSM1670396, IGRhCellID:RWPE1, Lonza:870, PharmacoDB:RWPE1_1336_2019, Progenetix:CVCL_3791, PubChem_Cell_line:CVCL_3791, Wikidata:Q54951497 |
|
|
CVCL_3791 |
2026-07-25 05:00:25 |
723 |
RWPE2-W99
Resource Report
Resource Website
|
RRID:CVCL_3793
|
Homo sapiens (Human)
|
|
Population: Caucasian.
|
PMID:16351690 PMID:20215515
|
Transformed cell line
|
Male |
|
|
|
CLO:CLO_0008907, ArrayExpress:E-MTAB-3610, ATCC:CRL-2853, cancercelllines:CVCL_3793, Cell_Model_Passport:SIDM01258, GEO:GSM827390, GEO:GSM1670397, PharmacoDB:RWPE2W99_1337_2019, Progenetix:CVCL_3793, Wikidata:Q54951500 |
cvcl_3792 |
|
CVCL_3793 |
2026-07-25 05:00:25 |
0 |
RKN
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_3156
|
Homo sapiens (Human)
|
Ovarian leiomyosarcoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6512337 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
|
|
|
CLO:CLO_0037102, EFO:EFO_0006745, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:478, BioSample:SAMN03471002, BioSample:SAMN10987621, cancercelllines:CVCL_3156, Cell_Model_Passport:SIDM00353, Cosmic-CLP:1298539, DepMap:ACH-000505, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1298539, GEO:GSM827213, GEO:GSM887540, GEO:GSM888623, GEO:GSM1670379, IARC_TP53:28219, JCRB:FDSC0033, JCRB:IFO50317, JCRB:JCRB0176, LiGeA:CCLE_288, LINCS_LDP:LCL-1803, PharmacoDB:RKN_1315_2019, PRIDE:PXD030304, Progenetix:CVCL_3156, Wikidata:Q54950536 |
|
|
CVCL_3156 |
2026-07-25 05:00:04 |
1 |
RKO-E6
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3787
|
Homo sapiens (Human)
|
Colon carcinoma
|
Caution: We believe that the clone called RKO-E6 by PubMed=7700629 is the clone RC10-1 originally described by PubMed=8387205 but it is also possible that it is RKO RC10-2 (Cellosaurus=CVCL_E7ET) or RKO RC10-3 (Cellosaurus=CVCL_E7EU) or RKO RC10-4 (Cellosaurus=CVCL_E7EV).
|
PMID:7700629 PMID:8202487 PMID:8387205 PMID:15161374 PMID:20215515 PMID:25485619 PMID:25877200 PMID:26589293
|
Cancer cell line
|
Sex unspecified |
RKO E6, RKOE6, RC10-1 |
|
|
BTO:BTO_0001891, CLO:CLO_0008827, EFO:EFO_0002318, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ATCC:CRL-2578, BioSample:SAMN03471683, BioSample:SAMN03472970, cancercelllines:CVCL_3787, CCRID:3101HUMTCHu118, Cell_Model_Passport:SIDM01253, CLS:305135, ColonAtlas:RKOE6, Cosmic:1184102, Cosmic:1187317, EGA:EGAS00001000610, IGRhCellID:RKOE6, PharmacoDB:RKOE6_1317_2019, Progenetix:CVCL_3787, Wikidata:Q54950558 |
cvcl_0504 |
|
CVCL_3787 |
2026-07-25 05:00:04 |
2 |
RL
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1660
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2313723 PMID:16960149 PMID:17363600 PMID:17495976 PMID:19358282 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23292937 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
|
|
|
BTO:BTO_0003230, CLO:CLO_0008828, EFO:EFO_0002319, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-2261, BioSample:SAMN01821593, BioSample:SAMN01821659, BioSample:SAMN03471851, BioSample:SAMN03472493, BioSample:SAMN10988269, cancercelllines:CVCL_1660, Cell_Model_Passport:SIDM01089, ChEMBL-Cells:CHEMBL3308515, ChEMBL-Targets:CHEMBL2366175, Cosmic:910861, Cosmic:1945189, Cosmic:2022593, Cosmic:2297011, Cosmic-CLP:910861, DepMap:ACH-000371, DSMZ:ACC-613, DSMZCellDive:ACC-613, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910861, GEO:GSM115984, GEO:GSM179647, GEO:GSM887543, GEO:GSM888626, GEO:GSM1035303, GEO:GSM1105702, GEO:GSM1670381, IARC_TP53:21288, IARC_TP53:25030, IGRhCellID:RL, LiGeA:CCLE_654, LINCS_LDP:LCL-1133, Lonza:1366, PharmacoDB:RL_1318_2019, PRIDE:PXD030304, Progenetix:CVCL_1660, PubChem_Cell_line:CVCL_1660, Wikidata:Q54950574 |
|
|
CVCL_1660 |
2026-07-25 05:00:04 |
8 |
RL95-2
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0505
|
Homo sapiens (Human)
|
Endometrial adenosquamous carcinoma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1541432 PMID:2436984 PMID:6339371 PMID:7798295 PMID:8123477 PMID:9887230 PMID:12893190 PMID:20164919 PMID:20215515 PMID:20944090 PMID:22460905 PMID:22710073 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31395879 PMID:33174010 PMID:35839778
|
Cancer cell line
|
Female |
RL95_2, RL-95-2, RL-952, RL952, RL95 |
|
|
BTO:BTO_0004491, CLO:CLO_0008830, EFO:EFO_0002320, MCCL:MCC:0000402, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1671, BCRC:60103, BCRJ:0366, BioGRID_ORCS_Cell_line:999, BioSample:SAMN03473219, BioSample:SAMN10987787, cancercelllines:CVCL_0505, CCRID:3101HUMTCHu198, CCRID:4201HUM-CCTCC00113, CCTCC:GDC0113, Cell_Model_Passport:SIDM01088, ChEMBL-Cells:CHEMBL3308843, ChEMBL-Targets:CHEMBL2366168, CLS:305062, Cosmic:713477, Cosmic:713489, Cosmic:809132, Cosmic:846175, Cosmic:871556, Cosmic:889117, Cosmic:930082, Cosmic:980637, Cosmic:1007165, Cosmic:1066226, Cosmic:1070808, Cosmic:1102377, Cosmic:1177623, Cosmic:1223487, Cosmic:1576464, Cosmic:1622899, Cosmic:1696756, Cosmic:2030481, Cosmic:2301551, Cosmic:2646617, Cosmic:2702441, Cosmic-CLP:930082, DepMap:ACH-000965, EGA:EGAS00001000978, GDSC:930082, GEO:GSM374977, GEO:GSM375436, GEO:GSM844677, GEO:GSM887542, GEO:GSM888625, GEO:GSM1670382, GEO:GSM3161728, GEO:GSM3161729, IARC_TP53:1114, IGRhCellID:RL952, KCB:KCB 2013033YJ, LiGeA:CCLE_166, LINCS_LDP:LCL-1506, Lonza:1501, PharmacoDB:RL952_1319_2019, PRIDE:PXD030304, Progenetix:CVCL_0505, PubChem_Cell_line:CVCL_0505, Wikidata:Q54950589 |
|
|
CVCL_0505 |
2026-07-25 05:00:05 |
140 |